Melanie de Almeida

Melanie de Almeida is an Associate at Forbion since September 2022 and serves as a Board Observer at Rampart Bioscience as of September 2023. Prior experience includes a PhD in Functional Genetics and Cancer Biology at the Research Institute of Molecular Pathology from August 2017 to April 2022, and a role as a Journalist at Labiotech.eu from February to July 2017. Melanie also worked as a Research Assistant at the German Rheumatism Research Center Berlin from March 2015 to November 2016 and completed an internship in Project Management and Regulatory Affairs Devices at Novo Nordisk from September 2014 to January 2015. Educational qualifications include a Master of Science (MSc) in Human Biology from Københavns Universitet earned between 2013 and 2016 and a Bachelor of Science (B.Sc.) in Molecular Biotechnology from RWTH Aachen University completed from 2010 to 2013.